
Search Clinical Trials
| Sponsor Condition of Interest |
|---|
|
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutan1
Melanoma and Skin Cancer Trials Limited
Cutaneous Melanoma, Stage II
Patients with a primary invasive melanoma are recommended to undergo excision of the
primary lesion with a wide margin. There is evidence that less radical margins of
excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm
margin of excision of the primary lesion for1 expand
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life. Type: Interventional Start Date: Dec 2019 |
|
Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment
Kent Imaging Inc
Peripheral Arterial Disease
The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can
accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative
Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical
assessments. expand
The objective of this trial is to determine if Near-infrared spectroscopy (NIRS) can accurately evaluate the degree of Peripheral Arterial Disease (PAD) during a Provocative Elevation Maneuver of the Lower Extremity (PEMLE) test, as compared to routine clinical assessments. Type: Observational Start Date: Feb 2024 |